DuPont director Edward Breen sells 89,845 shares

Available on EDGAR 11/09/2026 - 05:21 PM EST Accepted by SEC EDGAR 11/09/2026 - 05:21 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

DuPont de Nemours, Inc. director Edward D. Breen exercised 89,845 options on November 5, 2026, at $108.84 per share, acquiring 89,845 common shares and selling the same number at a weighted-average price of $146.4176 per share; trades ranged from $144.04 to $149.28. The reported options remaining after exercise were zero. On August 28, 2026, Breen received 35,551 shares as an annuity payment from 2024 GRAT 9; the amount includes shares acquired through dividend reinvestment.

Insider Trade Summary

Exercise and Sale: 89,845 shares ($3.38M approx. pre-tax spread)

Exercise and Sale 4 txns

Insider BREEN EDWARD D

Role Director

Sold 89,845 shs ($13.15M)

Approx. gross sale proceeds $13.15M

Approx. exercise cost $9.78M

Approx. pre-tax spread $3.38M

Share of Position Sold 41.4%

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy NQOs) F4	89,845	$0.00	$0.00
Exercise	Common Stock	89,845	$108.84	$9.78M
Sale	Common Stock F3	89,845	$146.41	$13.15M
Gift	Common Stock F1, F2	35,551	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to Buy NQOs) — 0 options (Direct); Common Stock — 127,275.5715 shares (Direct)

Holdings Before and After: Common Stock, 91,724.5715 to 127,275.5715 shares (Direct)

Footnotes (4)

1. F1. Represents annuity payment back to Mr. Breen from 2024 GRAT 9.
2. F2. Includes acquisition of shares pursuant to dividend reinvestment.
3. F3. Weighted average sales price of $146.4176. Trades ranged from $144.04 to $149.28. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.
4. F4. Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant, option shares may be used to satisfy withholding taxes.

Key Figures

Options exercised: 89,845 options Exercise price: $108.84 per share Common shares acquired on exercise: 89,845 shares +5 more

8 metrics

Options exercised 89,845 options November 5, 2026

Exercise price $108.84 per share Options exercised November 5, 2026

Common shares acquired on exercise 89,845 shares November 5, 2026

Common shares sold 89,845 shares November 5, 2026

Weighted-average sale price $146.4176 per share November 5, 2026

Sale price range $144.04 to $149.28 per share Trades on November 5, 2026

Options following exercise 0 options Following the November 5, 2026 exercise

Shares in annuity payment 35,551 shares August 28, 2026; 2024 GRAT 9

Key Terms

NQOs, weighted average sales price, annuity payment, dividend reinvestment

4 terms

NQOs financial

"Stock Options (Right to Buy NQOs)"

weighted average sales price financial

"Weighted average sales price of $146.4176"

annuity payment financial

"annuity payment back to Mr. Breen from 2024 GRAT 9"

dividend reinvestment financial

"acquisition of shares pursuant to dividend reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DD shares did Edward D. Breen sell, and at what price?

Edward D. Breen, a director, sold 89,845 common shares on November 5, 2026, at a weighted-average price of $146.4176 per share; trades ranged from $144.04 to $149.28. He exercised options for 89,845 shares at $108.84 per share that day, and no Rule 10b5-1 plan is reported.

What was Edward D. Breen's August 28, 2026 DD share transaction?

The 35,551-share transaction is described as an annuity payment back to Breen from 2024 GRAT 9. The reported amount includes shares acquired pursuant to dividend reinvestment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BREEN EDWARD D

(Last) (First) (Middle)

CHESTNUT RUN PLAZA 730

974 CENTRE ROAD

(Street)

WILMINGTON DELAWARE 19805

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DuPont de Nemours, Inc. [ DD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2026		G	V	35,551(1)	A	$0	127,275.5715(2)	D
Common Stock	11/05/2026		M		89,845	A	$108.84	217,120.5715	D
Common Stock	11/05/2026		S		89,845	D	$146.41(3)	127,275.5715	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy NQOs)	$108.84	11/05/2026		M		89,845		02/02/2018(4)	02/01/2027	Common Stock	89,845	$0	0	D

Explanation of Responses:

1. Represents annuity payment back to Mr. Breen from 2024 GRAT 9.

2. Includes acquisition of shares pursuant to dividend reinvestment.

3. Weighted average sales price of $146.4176. Trades ranged from $144.04 to $149.28. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.

4. Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant, option shares may be used to satisfy withholding taxes.

Remarks:

	Paige Fleming by Power of Attorney	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)